BreastDCEDL is a deep learning–ready DCE-MRI dataset of 2,070 breast cancer patients, sourced from I-SPY1, I-SPY2 and the DUKE cohort.
-
Updated
Jul 1, 2026 - Jupyter Notebook
BreastDCEDL is a deep learning–ready DCE-MRI dataset of 2,070 breast cancer patients, sourced from I-SPY1, I-SPY2 and the DUKE cohort.
Scientific Reports volume 11, Article number: 4037 (2021)
Code repository for the article **Leveraging Adversarial Learning for Pathological Fidelity in Virtual Staining (DGM4MICCAI, 2025)**
Free browser drills for pathologists: HER2, PD-L1, Ki-67, ER, MMR, TILs, cellularity, mitoses, lymph nodes, Gleason — compared with published interobserver agreement
Genomic characterization of HER2 IHC/FISH discordance in breast cancer using TCGA-BRCA data
Deep learning framework for automated HER2 scoring in breast cancer IHC histopathology using complementary local-global feature learning and bidirectional cross-attention.
Iambic Therapeutics — independent third-party profile of a public API surface, by API Evangelist. Iambic Therapeutics is a San Diego, California AI-driven drug discovery company founded in 2019 by Thomas Miller (CEO) and Fred Manby (CTO) that designs small-molecule therapeutics for oncology and other indications.
To associate your repository with the her2 topic, visit your repo's landing page and select "manage topics."